Molecular disruption of the MRN(95) complex induces radiation sensitivity in head and neck cancer

Laryngoscope

Volumn 113, Issue 9, 2003, Pages 1588-1594

  O'Malley Jr , Bert W ^a,b   Li, Daqing ^a   Carney, James ^a   Rhee, Joung ^a   Suntharalingam, Mohan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Dept of Otolaryngol Hd/Neck Surg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; DNA; MRN(95) PROTEIN COMPLEX; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RADIOTHERAPY; CELL CYCLE; DNA REPAIR; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TELOMERE; TUMOR CELL CULTURE;

ADENOVIRIDAE; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL SURVIVAL; CODON, NONSENSE; DNA REPAIR; DNA-BINDING PROTEINS; G2 PHASE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NUCLEAR PROTEINS; OTORHINOLARYNGOLOGIC NEOPLASMS; RADIATION TOLERANCE; TELOMERASE; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0041883556     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200309000-00034     Document Type: Article

References (21)

1. Million RR, Cassisi NJ. General principles for treatment of cancers in the head and neck: radiation therapy. In: Million RR, Cassisi NJ, eds. Management of Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia: JB Lippincott; 1984:77-90.
2. Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer 1972;29:1450-1454.
3. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: preliminary results of RTOG 9003. Proceeding American Society for Therapeutic Radiation and Oncology 1999;45:145.
4. Ward JF. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and repairability. Prog Nucl Acid Res Mol Biol 1988;35:95-125.
5. Petrini JH. The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response. Am J Hum Genet 1999;64:1264-1269.
6. Carney JP, Maser RS, Olivares H, et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 1998;93:477-486.
7. Stewart GS, Maser RS, Stankovic T, et al. The DNA doublestrand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 1999; 99:577-587.
8. Varon R, Vissinga C, Platzer M, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998;93:467-476.
9. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 1997;31:635-662.
10. van der Burgt I, Chrzanowska KH, Smeets D, Weemaes C. Nijmegen breakage syndrome. J Med Genet 1996;33: 153-156.
11. Weemaes CM, Smeets DF, van der Burgt CJ. Nijmegen breakage syndrome: a progress report. Int J Radiat Biol 1994;66:S185-S188.
12. He TC, Zhou S, Da Costa LT, Yu J, Kinzler KW, Vogelstein BA. Simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95:2509-2514.
13. Strunz AM, Peschke P, Waldeck W, Ehemann V, Kissel M, Debus J. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control. Int J Radiat Biol 2002;78:721-732.
14. Lim DS, Kim ST, Xu B, et al. ATM phosphorylates p95/nbsl in an S-phase checkpoint pathway. Nature 2000;404: 613-617.
15. Wu X, Ranganathan V, Weisman DS, et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response [comments]. Nature 2000;405: 477-482.
16. Allsopp R, Haley C. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995;219: 130-136.
17. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-1929.
18. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science 1990;249:1129-1133.
19. de Lange T, DePinho RA. Unlimited mileage from telomerase? Science 1999;283:947-949.
20. Mao L, El-Naggar AK, Fan YH, et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 1996;56:5600-5604.
21. Ogawa Y, Nishioka A, Hamada N, et al. Changes in telomerase activity of advanced cancers of oral cavity and oropharynx during radiation therapy: correlation with clinical outcome. Int J Mol Med 1998;2:301-307.